ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline

Published on 16 Dec 2024 on Zacks · via Yahoo Finance

AbbVie expects combined sales (risk-adjusted) of Skyrizi and Rinvoq to be more than $27 billion by...

Read the rest of the article

Start tracking your investments with Statfolio

We recently compiled a list of the Retirement Stock Portfolio: 7 Safe Dividend Stocks To Invest I...

Insider Monkey · via Yahoo Finance 19 Dec 2024

AbbVie (ABBV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a g...

Zacks · via Yahoo Finance 18 Dec 2024

Stocks Analysis by Michele Schneider covering: AbbVie Inc. Read Michele Schneider's latest articl...

Investing.com 17 Dec 2024

AbbVie expects combined sales (risk-adjusted) of Skyrizi and Rinvoq to be more than $27 billion b...

Zacks · via Yahoo Finance 16 Dec 2024

Luckily, most ETFs are very transparent products...at individual holdings, Exxon Mobil Corp (XOM)...

Zacks · via Yahoo Finance 13 Dec 2024

We recently published a list of 10 Best Safe Stocks To Buy According to Analysts. In this article...

Insider Monkey · via Yahoo Finance 12 Dec 2024

We recently compiled a list of the 11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in No...

Insider Monkey · via Yahoo Finance 11 Dec 2024

ABBV’s Zacks Rank AbbVie currently carries a Zacks Rank #3 (Hold). AbbVie Inc. Price AbbVie Inc....

Zacks · via Yahoo Finance 10 Dec 2024

Stocks recently featured in the blog include: Eli Lilly and Co. LLY, AbbVie Inc. ABBV, Gilead...

Zacks · via Yahoo Finance 10 Dec 2024

The board of AbbVie Inc. (NYSE:ABBV) has announced that it will be paying its dividend of $1.64 o...

Simply Wall St. · via Yahoo Finance 10 Dec 2024